New York Life Investment Management »

Peregrine Pharmaceuticals shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.0M 162k 12.35

More positions owned by New York Life Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
New York Life Invts Active E Nyli Mackay Core (CPLB)
New York Life Investments Et Candriam Us Lrg (IQSU)
Meta Platforms Cl A (META)
Broadcom (AVGO)
New York Life Investments Et Candriam Us Mid (IQSM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Vanguard World Mega Cap Index (MGC)
New York Life Investments Et Nyli Candriam In (IQSI)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Fltg Rate Nt Etf (FLOT)

View all positions for New York Life Investment Management